U.S. Paper and Forestry Products Stock News

If you are wondering whether Millrose Properties at around US$26.90 still offers value, the starting point is to understand what the current price implies about the business. The stock is up 14.1% over the last year, even though it has seen a 12.3% decline over the past week and a 3.0% decline over the past month, with a 9.8% decline year to date. This may have shifted how some investors think about its risk and reward trade off. Recent coverage has focused on Millrose Properties as a...

ArcBest (ARCB) stock was in focus after first quarter earnings showed sales of US$998.79 million and a net loss of US$1.04 million, with management highlighting stable demand despite winter weather and fuel headwinds. See our latest analysis for ArcBest. The Q1 update and ongoing buybacks have come against a backdrop of strong share price momentum, with a year to date share price return of 57.81% and a 1 year total shareholder return of 96.13%. The recent 7 day share price pullback of 4.54%...

CSX (CSX) is back in focus after it and Canadian Pacific Kansas City overhauled their Southeast Mexico Express premium rail service, which cut transit times and expanded cross-border reach between the U.S. Southeast, Texas and Mexico. See our latest analysis for CSX. The upgraded Southeast Mexico Express service lands at a time when CSX’s 1 month share price return of 7.34% and year to date share price return of 22.58% sit alongside a 1 year total shareholder return of 55.86%. This suggests...

Capital Clean Energy Carriers (CCEC) has just wrapped up FY 2025 with fourth quarter revenue of US$86.8 million and basic EPS of US$0.46. Trailing 12 month EPS came in at US$1.92 as earnings over that period were very large compared with the prior year. The company has seen revenue on a trailing 12 month basis move from US$339.5 million in FY 2024 to US$392.7 million in FY 2025. Over the same period, EPS shifted from US$0.13 to US$1.92 and net profit margin moved from 2.2% to 28.9%. These...

Genworth Financial reported past first-quarter 2026 results with revenue of US$1,777 million and net income of US$47 million, alongside modestly lower earnings per share year over year. The company also completed a sizeable share repurchase program and highlighted Enact’s contribution and the build-out of CareScout as key parts of its longer-term plan. Next, we will examine how Genworth’s continued share repurchases shape the company’s investment narrative and its appeal to different...

GPGI (GPGI) is drawing fresh attention after first quarter 2026 results combined record sales at CompoSecure with a US$235 million net loss and weaker Husky performance, along with a new international commercial leadership appointment. See our latest analysis for GPGI. The first quarter loss and Husky headwinds have coincided with sharp share price weakness, with a 1 day share price return of negative 25.9% and a 90 day share price return of negative 47.1%. However, the 3 year total...

If you are wondering whether DENTSPLY SIRONA stock is starting to look interesting at current levels, its recent price and valuation signals give you a lot to think about. The share price sits at US$10.96 after a 6.7% decline over the last week, a 4.9% decline over the last month and a 28.5% decline over the last year, which may change how you view both its risk and potential reward. Recent coverage around DENTSPLY SIRONA has focused on its position within the medical equipment space and how...

Repligen (RGEN) is back in focus after its first quarter 2026 earnings, where profit topped market expectations, full year adjusted earnings guidance moved higher, and the stock gained 7.3% on the news. See our latest analysis for Repligen. Beyond the post earnings jump, Repligen’s 7 day share price return of 6.86% and 30 day share price return of 9.66% sit against a year to date share price decline of 23.07%. The 1 year total shareholder return of a 1.11% decline and 3 year total shareholder...

What Crane’s latest earnings and M&A comments mean for investors Crane (CR) just paired a Q1 earnings beat with a slight uptick in full year adjusted EPS guidance, yet a softer operating margin and active acquisition agenda are shaping how investors reassess the stock. See our latest analysis for Crane. Crane’s recent Q1 earnings beat, slight full year EPS guidance increase, dividend affirmation, and active M&A commentary come after a 1 year total shareholder return of 7.6%. The 3 year total...

In early May 2026, Clean Harbors, Inc. reported first-quarter 2026 results showing revenue of US$1,459.54 million and net income of US$63.2 million, and issued full-year 2026 GAAP net income guidance of US$421 million to US$472 million. The quarter also featured record safety performance, strong landfill volume growth tied to PFAS and project work, and higher full-year adjusted EBITDA guidance supported by operational efficiency initiatives, including AI deployment and new field service...

Recently, Legend Biotech expanded its scientific advisory board with six leading experts in oncology and cell therapy and, together with Janssen, agreed to increase CARVYKTI manufacturing capacity at Janssen’s Raritan, New Jersey facility to support its cell therapy ambitions. This combination of deeper scientific guidance and scaled manufacturing marks a meaningful step in Legend’s efforts to build an end-to-end cell therapy platform targeting high unmet medical needs. We’ll now examine how...

In the first quarter of 2026, First Solar reported sales of US$1,044.24 million and net income of US$346.62 million, with basic earnings per share from continuing operations of US$3.23, all higher than a year earlier. Alongside these results, the company reaffirmed its 2026 outlook, including expected module volumes of 17.0–18.2 GW and net sales of US$4.90–US$5.20 billion, reinforcing visibility into its order book and manufacturing plans. Building on this earnings strength and reaffirmed...

Estée Lauder Companies (NYSE:EL) agreed to a US$210 million settlement of a shareholder lawsuit over disclosure of grey-market sales in China. The company also announced a global workforce reduction targeting up to 10,000 jobs, nearly 20% of staff, under its expanded Profit Recovery and Growth Plan. Job cuts are expected to focus on department store beauty advisors, with a pivot toward digital channels and different selling models. For investors following NYSE:EL, these moves come at a time...

DigitalOcean Holdings (NYSE:DOCN) has rolled out an AI-Native Cloud platform with a new Inference Engine, presented at its Deploy 2026 event. The company completed an $888 million equity raise aimed at funding AI infrastructure and strengthening its balance sheet. Market attention has increased alongside analyst upgrades and DigitalOcean’s move from the S&P SmallCap 600 to the S&P MidCap 400. DigitalOcean’s repositioning around AI-focused cloud services is coming at a time when the stock...

Why Saia (SAIA) is on investors’ radar right now Saia (SAIA) has drawn fresh attention after a recent share price move, with the stock showing strong trailing returns over the past year and past 3 months. This performance has prompted closer scrutiny of its fundamentals. See our latest analysis for Saia. Despite a small 1-day share price decline, Saia’s 30-day share price return of 19.52% and 1-year total shareholder return of 68.91% point to momentum building on top of its longer term...

Palantir Technologies (NasdaqGS:PLTR) is participating in the U.S. Army's "Right to Integrate" (R2I) Hackathon initiative. The project focuses on weaving Palantir's AI platforms into critical military technology systems to support interoperability and data access. The R2I effort centers on modular, open system architectures for future command, control and data sharing across Army programs. Palantir has built its business around data integration, analytics and AI platforms used by...

In recent weeks, Encompass Health Corporation reported higher first‑quarter 2026 sales of US$1,586.6 million and net income of US$194.5 million, raised its full‑year net operating revenue guidance, continued share repurchases under its long‑running buyback, opened a new 50‑bed rehabilitation hospital in Concordville, Pennsylvania, and declared a quarterly dividend of US$0.19 per share payable on July 15, 2026. Together, the earnings beat, guidance increase, capacity expansion and ongoing...

In the first quarter of 2026, AGCO Corporation reported higher sales of US$2,342.9 million and net income of US$55.0 million, while also completing a US$250.0 million share repurchase program under its existing authorization. The company reinforced its disciplined capital allocation approach by accelerating technology-focused acquisitions, boosting shareholder returns through higher dividends and additional buybacks, and reshaping its financing joint ventures in North America. With AGCO now...

Gap Inc. co founder Doris Fisher has died at age 94. Her passing marks an important moment for NYSE:GAP, given her role in shaping the company’s identity, culture, and creative direction. The news comes as Gap continues its focus on brand reinvigoration and broader business transformation. For investors watching NYSE:GAP, this moment comes with the stock trading around $23.9, after a 6.8% gain over the past year and a very large return over three years. Over five years the stock shows a...

Merck (NYSE:MRK) faces an upcoming Gardasil vaccine safety trial scheduled for late July, focusing on product safety and potential liability claims. The company has also published new research on a large scale, enzyme enabled synthesis route for its oral PCSK9 inhibitor candidate. This synthesis work could help support development of what may become one of the first oral PCSK9 treatments for cholesterol management. Merck enters these developments with its stock at $112.3 and a return of...

There's been a notable change in appetite for SmartRent, Inc. ( NYSE:SMRT ) shares in the week since its quarterly...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

The latest earnings release from NCS Multistage Holdings, Inc. ( NASDAQ:NCSM ) disappointed investors. We did some...

Mettler-Toledo International (MTD) closed out FY 2025 with fourth quarter revenue of US$1,129.7 million and basic EPS of US$14.02, setting the tone for a year where trailing twelve month revenue reached US$4.0 billion and EPS came in at US$42.17. Over recent quarters the company has seen revenue move from US$954.5 million in Q3 2024 to US$1,129.7 million in Q4 2025, while quarterly EPS stepped from US$10.01 to US$14.02. This has left investors focused on how these trends flow through to...